Junji Tsurutani

Junji Tsurutani

UNVERIFIED PROFILE

Are you Junji Tsurutani?   Register this Author

Register author
Junji Tsurutani

Junji Tsurutani

Publications by authors named "Junji Tsurutani"

Are you Junji Tsurutani?   Register this Author

88Publications

1879Reads

21Profile Views

[fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification.

Int J Cancer 2019 Dec 24;145(12):3414-3424. Epub 2019 May 24.

Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32408DOI Listing
December 2019

Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury.

Int J Mol Sci 2019 Aug 17;20(16). Epub 2019 Aug 17.

Division of Allergology and Respiratory Medicine, Department of Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20164021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720446PMC
August 2019

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib.

J Vis Exp 2019 Jun 26(148). Epub 2019 Jun 26.

Division of Allergology and Respiratory Medicine, Department of Medicine, Showa University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/59473DOI Listing
June 2019

Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.

Breast Cancer 2019 Mar 15;26(2):235-243. Epub 2018 Oct 15.

Clinical Planning and Development Department, Eisai Co., Ltd., 4-6-10, Koishikawa, Bunkyo-ku, Tokyo, 112-8088, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12282-018-0919-8
Publisher Site
http://dx.doi.org/10.1007/s12282-018-0919-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394617PMC
March 2019

and Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in .

Mol Cancer Ther 2019 01 15;18(1):112-126. Epub 2018 Oct 15.

Advanced Cancer Translational Research Institute (formerly, Institute of Molecular Oncology), Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0591DOI Listing
January 2019

DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.

Int J Cancer 2017 10 12;141(8):1682-1689. Epub 2017 Jul 12.

Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayamashi, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30870DOI Listing
October 2017

Incidence of carnitine deficiency in patients with cancer pain: A pilot study.

Mol Clin Oncol 2017 Mar 7;6(3):331-333. Epub 2017 Feb 7.

Department of Psychosomatic Medicine, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2017.1159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403195PMC
March 2017

Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.

Invest New Drugs 2016 06 9;34(3):394-6. Epub 2016 Feb 9.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0329-8DOI Listing
June 2016

Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report.

Anticancer Drugs 2016 Mar;27(3):251-3

aDepartment of Medical Oncology, Kinki University Faculty of Medicine bDepartment of Medical Oncology, Kishiwada City Hospital, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000317DOI Listing
March 2016

Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors.

Invest New Drugs 2015 Apr 12;33(2):380-8. Epub 2014 Dec 12.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0196-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387254PMC
April 2015

Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer.

J Thorac Oncol 2015 Feb;10(2):346-52

*Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan; †Center for Clinical and Translational Research, Faculty of Medicine, Kyusyu University Hospital, Fukuoka, Japan; ‡Department of Internal Medicine, Suita Municipal Hospital, Osaka, Japan; §Department of Medical Oncology, Nara Hospital, Kinki University Faculty of Medicine, Nara, Japan; ║Department of Medicine, Division of Respirology, Neurology, and Rheumatology, Kurume University Hospital, Fukuoka, Japan; ¶Department of Medical Oncology, Kishiwada Municipal Hospital, Osaka, Japan; #Department of Thoracic Oncology, Kansai Medical University, Hirakata Hospital, Osaka, Japan; **Department of Medical Oncology, National Kyushu Cancer Centre, Fukuoka, Japan; ††Department of Medical Oncology, National Kyushu Cancer Centre, Fukuoka, Japan; ‡‡Nippon Boehringer Ingelheim Co. Ltd., Medical Development Division, Hyogo, Japan; and §§Clinical Pharmacokinetics/Pharmacodynamics Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000395DOI Listing
February 2015

The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.

Breast Cancer 2015 Jan 9;22(1):5-15. Epub 2014 Sep 9.

Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0563-xDOI Listing
January 2015

Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: phase i study in Japanese patients with advanced solid malignancies and advanced breast cancer.

Invest New Drugs 2014 Oct 31;32(5):946-54. Epub 2014 May 31.

Department of Medical Oncology, Kinki University School of Medicine, 589-8511, 377-2 Ohno-Higashi, Osakasayama, Osaka, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0112-7DOI Listing
October 2014

Regression of brain metastases from breast cancer with eribulin: a case report.

BMC Res Notes 2013 Dec 18;6:541. Epub 2013 Dec 18.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-0500-6-541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878316PMC
December 2013

Perspectives in drug development for cancer therapy in Asia.

Chin Clin Oncol 2012 Dec;1(2):17

Department of Medical Oncology, Kinki University Faculty of Medicine, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2012.11.12DOI Listing
December 2012

[Resistant mechanisms against breast cancer treatment and therapeutic strategies].

Nihon Rinsho 2012 Nov;70 Suppl 8:336-40

Department of Medical Oncology, Kinki University School of Medicine.

View Article

Download full-text PDF

Source
November 2012

Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.

Jpn J Clin Oncol 2012 Jun 28;42(6):528-33. Epub 2012 Mar 28.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hys042DOI Listing
June 2012

Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.

Anticancer Res 2012 May;32(5):1805-9

Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan.

View Article

Download full-text PDF

Source
May 2012

Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors.

Invest New Drugs 2012 Apr 20;30(2):639-46. Epub 2010 Oct 20.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-010-9565-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277823PMC
April 2012

Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure.

Biochem Biophys Res Commun 2011 Apr 4;407(1):219-24. Epub 2011 Mar 4.

Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohnohigashi, Osakasayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2011.03.002DOI Listing
April 2011

A phase I study of gemcitabine plus irinotecan for advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904).

Jpn J Clin Oncol 2010 Oct 3;40(10):992-4. Epub 2010 Jun 3.

Department of Medical Oncology, Kinki University School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hyq079DOI Listing
October 2010

Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.

Anticancer Res 2006 Jan-Feb;26(1B):777-81

Kinki University School of Medicine, Department of Medical Oncology, Japan.

View Article

Download full-text PDF

Source
June 2006

Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.

Cancer Res 2005 Aug;65(16):7137-44

Genetics Branch and Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute and the National Naval Medical Center, Bethesda, Maryland 20889, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1125DOI Listing
August 2005

Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells.

Carcinogenesis 2005 Jul 24;26(7):1182-95. Epub 2005 Mar 24.

Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20889, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgi072DOI Listing
July 2005

Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.

Cancer Chemother Pharmacol 2004 Dec 10;54(6):573-7. Epub 2004 Sep 10.

Division of Respiratory Disease, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Okayama, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0805-2DOI Listing
December 2004

Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer.

J Natl Cancer Inst 2004 Dec;96(23):1795; author reply 1795-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djh342DOI Listing
December 2004

The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells.

Mol Cancer Ther 2004 Nov;3(11):1397-402

Division of Molecular and Clinical Microbiology, Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

View Article

Download full-text PDF

Source
November 2004

Expression and functional analyses of breast cancer resistance protein in lung cancer.

Clin Cancer Res 2003 Aug;9(8):3052-7

Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki 852-8501, Japan.

View Article

Download full-text PDF

Source
August 2003

Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecan.

Lung Cancer 2002 Mar;35(3):299-304

Fourth Department of Internal Medicine, Kinki University School of Medicine, Ohonohigashi 377-2, Osakasayama, Osaka 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(01)00425-1DOI Listing
March 2002

Mutational analysis of the beta-tubulin gene in lung cancer.

Lung Cancer 2002 Jan;35(1):11-6

Fourth Department of Internal Medicine, Kinki University School of Medicine, Ohonohigashi 377-2, Osakasayama, 589-8511, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(01)00291-4DOI Listing
January 2002